@kekes.plot's GLP-1 injection claims, fact-checked

What does this TikTok actually claim?

Creator @kekes.plot tells viewers that GLP-1 injections take "less than 2 minutes once a week" and promises to answer "all your GLP-1 questions." The video appears to be aimed at the #glp1community, suggesting it's targeting people already using or considering medications like semaglutide or tirzepatide.

While the caption is brief, the timing claim is specific enough to fact-check. The creator positions themselves as an authority on GLP-1 medications by offering to answer questions about these prescription drugs.

Is the injection timing accurate?

The "less than 2 minutes" claim is actually generous. Most people can complete a GLP-1 injection in 30-60 seconds once they're familiar with the process. Pen injectors like those used for Ozempic and Wegovy are designed for quick subcutaneous administration.

The weekly timing applies to semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound), which are both dosed once weekly. However, liraglutide (Saxenda) requires daily injections. The creator doesn't specify which GLP-1 medication they're discussing, making their advice incomplete.

Clinical trials confirm the weekly dosing schedule. The STEP 1 trial (Wilding et al., NEJM, 2021) used once-weekly 2.4mg semaglutide injections, while the SURMOUNT-1 trial (Jastreboff et al., NEJM, 2022) tested weekly tirzepatide doses up to 15mg.

What's missing from this advice?

The creator's promise to answer "all your GLP-1 questions" is problematic without proper medical credentials. These medications require careful dose escalation, monitoring for side effects, and contraindication screening that goes far beyond injection technique.

Semaglutide starts at 0.25mg weekly and increases to 2.4mg over 16-20 weeks to minimize gastrointestinal side effects. The STEP trials found that 74% of patients experienced nausea with the 2.4mg dose. This titration schedule isn't something you learn from TikTok.

The video also doesn't address serious considerations like contraindications in patients with medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2. The FDA requires black box warnings on these medications for good reason.

Should you trust TikTok for GLP-1 guidance?

While @kekes.plot gets the basic injection timing right, social media isn't the place for comprehensive medication counseling. These drugs carry significant side effects and require medical supervision.

The STEP 1 trial reported discontinuation rates of 7% due to adverse events with semaglutide versus 3.1% with placebo. Common issues include nausea (58% vs 16% placebo), diarrhea (30% vs 16%), and vomiting (24% vs 5%). You won't get proper side effect management from a 15-second TikTok.

Real medication education requires discussing individual risk factors, drug interactions, and monitoring requirements. The injection technique is the easy part.